StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -60.6%, against 8.8% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-60.6%−69.4
FY2024Dec 31, 20248.8%−12.4
FY2023Dec 31, 202321.3%−4.0
FY2022Dec 31, 202225.3%–

More Zhengye Biotechnology figures

See a number that looks wrong?